Content about Technology

December 7, 2010

We’re making big changes around here in 2011 — and we’re doing it because you told us to.


Whenever we ask one of our readers what they want from Drug Store News, inevitably, the answer always is: “Tell me something I don’t already know about.”


That’s the problem with most trade magazines today — by the time you get the issue, it’s all old news; often more than a month old by the time it lands on your desk. 


December 6, 2010

Coty has added Chinese skin care company, TJoy, to its skin care portfolio, which provides Coty a solid foothold in China through TJoy's existing distribution channels, and also gives Coty a platform to expand its research and development capabilities.

NEW YORK — Coty has added Chinese skin care company, TJoy, to its skin care portfolio, which provides Coty a solid foothold in China through TJoy's existing distribution channels, and also gives Coty a platform to expand its research and development capabilities.

December 6, 2010

DSE Healthcare Solutions on Sunday evening announced the launch of Safari Towels, a new product extending from its Anti Monkey Butt Powder brand, to its Facebook fan base of almost 39,000.

EDISON, N.J. — DSE Healthcare Solutions on Sunday evening announced the launch of Safari Towels, a new product extending from its Anti Monkey Butt Powder brand, to its Facebook fan base of almost 39,000.

“Our new Safari Towels ... so hot off the presses they aren't even in stores yet!” the Anti Monkey Butt Powder status read. “Make a cool gift ... from cyclists to soldiers, [they're] great to have on hand for a ‘shower on the go.’ See them in our online store.”

December 6, 2010

NBTY on Monday named Jeffrey Nagel to the CEO post, succeeding Scott Rudolph, who will maintain his position as chairman.

RONKONKOMA, N.Y. — NBTY on Monday named Jeffrey Nagel to the CEO post, succeeding Scott Rudolph, who will maintain his position as chairman.

Nagel comes to NBTY from General Electric, where he held senior leadership positions in several GE businesses addressing a variety of end markets, including oil and gas, consumer electronics, technology and aviation. He most recently served as head of GE Oil and Gas Global Services and was based in Florence, Italy.

December 6, 2010

A biotech drug made by Roche subsidiary Genentech allowed patients with a blood cancer, who did not show symptoms, to delay starting on chemotherapy or radiotherapy, and decreased the risk of their disease worsening, according to results of a late-stage clinical trial.

SOUTH SAN FRANCISCO, Calif. — A biotech drug made by Roche subsidiary Genentech allowed patients with a blood cancer, who did not show symptoms, to delay starting on chemotherapy or radiotherapy, and decreased the risk of their disease worsening, according to results of a late-stage clinical trial.

December 6, 2010

Two-and-a-half years after joining the company, Robin Michel is leaving as president of the Giant-Landover division of Ahold USA to pursue other opportunities, the company confirmed Monday.

LANDOVER, Md. — Two-and-a-half years after joining the company, Robin Michel is leaving as president of the Giant-Landover division of Ahold USA to pursue other opportunities, the company confirmed Monday.

Michel will depart at the end of the month, according to Ahold USA spokesperson Sara Neumann. She will be replaced on a temporary basis as operations chief by Don Sussman, EVP supply chain at Ahold, while the company conducts a search for a successor.

December 6, 2010

The Consumer Healthcare Products Association recently named GlaxoSmithKline veteran Janet Carter-Smith chair of the CHPA Retailer Liaison Steering Committee, effective Jan. 1.

WASHINGTON — The Consumer Healthcare Products Association recently named GlaxoSmithKline veteran Janet Carter-Smith chair of the CHPA Retailer Liaison Steering Committee, effective Jan. 1.

Carter-Smith will be the third chair of this committee, succeeding David Howenstine, VP customer and industry development at Pfizer Consumer Healthcare, whose term ends at the end of the year.

December 6, 2010

An investigational drug made by Watson Pharmaceuticals and Columbia Labs reduced the risk of premature birth, according to results of late-stage clinical trial.

MORRISTOWN, N.J. — An investigational drug made by Watson Pharmaceuticals and Columbia Labs reduced the risk of premature birth, according to results of a late-stage clinical trial.

The two companies announced results Monday of a phase-3 trial of Prochieve (progesterone), a vaginal gel, saying that it produced a significant reduction in the number of preterm births. The trial was conducted under a collaboration with the Eunice Kennedy Shriver National Institute of Child Health and Human Development, part of the National Institutes of Health.

December 6, 2010

Consumers see smart phones as future personal, coupon-clipping shopper assistants, a global survey released Monday by Accenture found.

NEW YORK — Consumers see smart phones as future personal, coupon-clipping shopper assistants, a global survey released Monday by Accenture found. According to the survey, 79% of smart-phone users would find it useful to download money-off coupons to their phones, and 73% of those shoppers would be receptive to being pinged with instant money-off coupons as they passed by an item in a store.

December 3, 2010

Fresh from securing a deal to sell his company to Cardinal Health for $1.3 billion, Kinray owner, president and CEO Stewart Rahr is turning more attention to his crusade to promote his friend Donald Trump as a candidate for president in 2012.

WHITESTONE, N.Y. — Fresh from securing a deal to sell his company to Cardinal Health for $1.3 billion, Kinray owner, president and CEO Stewart Rahr is turning more attention to his crusade to promote his friend Donald Trump as a candidate for president in 2012.

December 3, 2010

Community pharmacists still are among the nation’s most trusted professionals. That’s the finding from Gallup’s newly released "Honesty and Ethics" survey.

ALEXANDRIA, Va. — Community pharmacists still are among the nation’s most trusted professionals.

December 3, 2010

The forward-looking vision employed by Gov. Jay Nixon in exploring “next steps” in fighting methamphetamine abuse before even the last step has been put into place and enacted is, in a matter of speaking, extremely short-sighted. It doesn’t even make fiscal sense, because the National Precursor Log Exchange will do more to curb many of the costs associated with fighting meth addicts without conversely increasing the costs associated with fighting a cold. And truth be told, there are probably a lot more stuffy heads in Missouri than there are meth addicts.

WHAT IT MEANS AND WHY IT'S IMPORTANT — The forward-looking vision employed by Gov. Jay Nixon in exploring “next steps” in fighting methamphetamine abuse before even the last step has been put into place and enacted is, in a matter of speaking, extremely short-sighted. It doesn’t even make fiscal sense, because the National Precursor Log Exchange will do more to curb many of the costs associated with fighting meth addicts without conversely increasing the costs associated with fighting a cold.

December 3, 2010

Prestige Brands Holdings on Thursday named Ron Lombardi its new CFO, effective Dec. 6. The position had been vacated by the retirement of Pete Anderson.

IRVINGTON, N.Y. — Prestige Brands Holdings on Thursday named Ron Lombardi its new CFO, effective Dec. 6. The position had been vacated by the retirement of Pete Anderson.

“[Lombardi] is a results-oriented financial professional whose extensive background in business development, acquisitions and divestitures, and debt and equity structuring will serve Prestige well as we move into our next phase of growth following our recent acquisition of Blacksmith Brands,” stated Matthew Mannelly, Prestige president and CEO.

December 3, 2010

The Specialty Pharmacy Nursing Network has entered a partnership with ViroPharma’s CinryzeSolutions support program, a training and monitoring program for patients using ViroPharma’s Cinryze (C1 esterase inhibitor [human]) who wish to administer the drug themselves.

SARASOTA, Fla. — The Specialty Pharmacy Nursing Network has entered a partnership with ViroPharma’s CinryzeSolutions support program, a training and monitoring program for patients using ViroPharma’s Cinryze (C1 esterase inhibitor [human]) who wish to administer the drug themselves.

Cinryze is a drug administered via infusion for the treatment of hereditary angioedema, and the partnership will allow patients to receive training and follow-up support from SPNN nurses, as well as direction from their physicians.

December 3, 2010

Pharmacy advocates are using every tool they can to spread the message that pharmacists bring a lot more than prescription services to the healthcare table. So how about a 341-ft. digital billboard looming above Times Square?

WHAT IT MEANS AND WHY IT'S IMPORTANT — Pharmacy advocates are using every tool they can to spread the message that pharmacists bring a lot more than prescription services to the healthcare table. So how about a 341-ft. digital billboard looming above Times Square?

December 2, 2010

Industry veteran Bob Kwait, chairman and COO of Bob Kwait Consulting Group, and FreshDirect chairman and CEO Richard Braddock were honored Wednesday during the 2010 Consumer Products "Good Scout" Award Luncheon in New York.

NEW YORK — Industry veteran Bob Kwait, chairman and COO of Bob Kwait Consulting Group, and FreshDirect chairman and CEO Richard Braddock were honored Wednesday during the 2010 Consumer Products "Good Scout" Award Luncheon in New York.

The annual luncheon, presented by the Greater New York Councils of Boy Scouts of America, was held at Hilton New York.

December 2, 2010

Merck announced on Thursday it has inked a deal to acquire an insulin maker.

WHITEHOUSE STATION, N.J., and BEVERLY, Mass. (Dec. 2) Merck announced on Thursday it has inked a deal to acquire an insulin maker.

December 2, 2010

Oramed Pharmaceuticals, a developer of oral drug delivery solutions, has published an article in the Journal of Diabetes Science and Technology’s November issue describing evaluation of the company’s glucagon-like peptide (GLP-1) analog formulation (ORMD-0901) in regulating glucose excursions in animal models.

JERUSALEM — Oramed Pharmaceuticals, a developer of oral drug delivery solutions, has published an article in the Journal of Diabetes Science and Technology’s November issue describing evaluation of the company’s glucagon-like peptide (GLP-1) analog formulation (ORMD-0901) in regulating glucose excursions in animal models.

December 1, 2010

Skin care company Beiersdorf has established an independent affiliate in Vietnam called "Beiersdorf Vietnam Limited," laying the groundwork for further growth in Southeast Asia and for meeting the rising demand for skin care products in Vietnam.

HAMBURG, Germany (Dec. 1) Skin care company Beiersdorf has established an independent affiliate in Vietnam called "Beiersdorf Vietnam Limited," laying the groundwork for further growth in Southeast Asia and for meeting the rising demand for skin care products in Vietnam.

From the company's local headquarters in Ho Chi Minh City (Saigon) the new global Beiersdorf strategy "Focus on Skincare. Closer to Markets." will be implemented regionally to expand sales in a targeted manner. The goal is to double turnover in Vietnam by 2015.

December 1, 2010

A consumer products giant and a big-box retailer are looking to connect deployed members of the U.S. military with their families during the holiday season, with help from the United Service Organizations.

CINCINNATI — A consumer products giant and a big-box retailer are looking to connect deployed members of the U.S. military with their families during the holiday season, with help from the United Service Organizations.

December 1, 2010

One hundred new drugs and vaccines are in development to treat HIV/AIDS and related conditions, according to a new report by a pharmaceutical industry trade group.

WASHINGTON — One hundred new drugs and vaccines are in development to treat HIV/AIDS and related conditions, according to a new report by a pharmaceutical industry trade group.

December 1, 2010

Drug maker Watson Pharmaceuticals has made an emergency oral contraceptive available by prescription in the United States, the company said Wednesday.

MORRISTOWN, N.J. — Drug maker Watson Pharmaceuticals has made an emergency oral contraceptive available by prescription in the United States, the company said Wednesday.

Watson announced the launch of Ella (ulipristal acetate) in the 30-mg dose, designed to prevent pregnancy up to five days after unprotected sex or failure of other contraceptives. The drug is designed to delay ovulation for five days, the amount of time that sperm can survive in the female genital tract.

November 30, 2010

The Institute of Medicine on Tuesday issued a report on the dietary reference intake levels for vitamin D and calcium at the behest of both the U.S. and Canadian governments. IOM recommended a slight increase in vitamin D intake, but also suggested that the need for either vitamin D or calcium may be overstated.

WASHINGTON — The Institute of Medicine on Tuesday issued a report on the dietary reference intake levels for vitamin D and calcium at the behest of both the U.S. and Canadian governments. IOM recommended a slight increase in vitamin D intake, but also suggested that the need for either vitamin D or calcium may be overstated.

November 30, 2010

The president of drug maker Merck now will fill an additional position at the company: CEO.

WHITEHOUSE STATION, N.J. — The president of drug maker Merck now will fill an additional position at the company: CEO.

Merck's board of directors elected president and board member Kenneth Frazier as the company's next leader, effective Jan. 1. Frazier will succeed Richard Clark, who has served as Merck's CEO since 2005. Clark will continue as chairman of the board, the drug maker said.

November 30, 2010

The spate of recent product recalls may be eroding consumer confidence in the Food and Drug Administration, according to a PricewaterhouseCoopers survey of 1,000 Americans released Tuesday.

NEW YORK — The spate of recent product recalls may be eroding consumer confidence in the Food and Drug Administration, according to a PricewaterhouseCoopers survey of 1,000 Americans released Tuesday.

Approximately one-half of respondents reported they think the FDA does a good job, but more than one-third (36%) of U.S. consumers said they have lost confidence in the FDA over the past two years as a result of high profile safety concerns and product recalls.